KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Capital Expenditures (2016 - 2025)

Nu Skin Enterprises' Capital Expenditures history spans 17 years, with the latest figure at $10.8 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 14.49% year-over-year to $10.8 million; the TTM value through Dec 2025 reached $34.3 million, down 17.57%, while the annual FY2025 figure was $34.3 million, 17.57% down from the prior year.
  • Capital Expenditures for Q4 2025 was $10.8 million at Nu Skin Enterprises, up from $9.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $25.5 million in Q3 2022 and bottomed at $18000.0 in Q2 2025.
  • The 5-year median for Capital Expenditures is $12.4 million (2024), against an average of $13.1 million.
  • The largest annual shift saw Capital Expenditures surged 88.08% in 2022 before it tumbled 99.78% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $18.2 million in 2021, then fell by 24.4% to $13.8 million in 2022, then skyrocketed by 47.91% to $20.4 million in 2023, then plummeted by 38.27% to $12.6 million in 2024, then fell by 14.49% to $10.8 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Capital Expenditures are $10.8 million (Q4 2025), $9.9 million (Q3 2025), and $18000.0 (Q2 2025).